| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58 |
| filingDate |
1998-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7620b7b7f323fe4a717d6b7f308cdce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7edf0913ac5db531c874dba4796be782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b95892c5a18b8162e4ac7b92e17ab8be |
| publicationDate |
1999-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9932476-A1 |
| titleOfInvention |
Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| abstract |
This invention is related to novel carboxyl substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008010022-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008010022-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1803715-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7297704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6699860-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0248134-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02085891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0248134-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7560575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03033468-A1 |
| priorityDate |
1997-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |